Insulatard: Opinion on medicine for use outside EU
Table of contents
Opinion on medicine for use outside the European Union
Insulatard is a medicine for treating diabetes. It contains human insulin as its active substance.
This overview is for Insulatard intended for use outside the EU. An identical product with the same name is authorised in the European Union. For Insulatard intended for use outside EU there is an additional storage option requiring less refrigeration.
|Name of medicinal product||
|Agency opinion number||
Insulin human (RDNA)
|International non-proprietary name (INN) or common name||
|Therapeutic area (MeSH)||
|Anatomical therapeutic chemical (ATC) code||
Novo Nordisk A/S
|Date of opinion||
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturer responsible for batch release
- Annex IIB - Recommendations to the opinion holder - conditions of use
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Drugs used in diabetes
Treatment of diabetes mellitus